NO180084C - Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater - Google Patents
Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivaterInfo
- Publication number
- NO180084C NO180084C NO930306A NO930306A NO180084C NO 180084 C NO180084 C NO 180084C NO 930306 A NO930306 A NO 930306A NO 930306 A NO930306 A NO 930306A NO 180084 C NO180084 C NO 180084C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically active
- analogous process
- dihydropyridine derivatives
- dihydropyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL9001752A NL9001752A (nl) | 1990-08-02 | 1990-08-02 | Nieuwe 1,4-dihydropyridinederivaten. |
PCT/EP1991/001442 WO1992002503A1 (en) | 1990-08-02 | 1991-07-31 | Novel 1,4-dihydropyridine derivatives |
Publications (4)
Publication Number | Publication Date |
---|---|
NO930306D0 NO930306D0 (no) | 1993-01-29 |
NO930306L NO930306L (no) | 1993-01-29 |
NO180084B NO180084B (no) | 1996-11-04 |
NO180084C true NO180084C (no) | 1997-02-12 |
Family
ID=19857506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO930306A NO180084C (no) | 1990-08-02 | 1993-01-29 | Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater |
Country Status (13)
Country | Link |
---|---|
US (1) | US5378718A (no) |
EP (1) | EP0541634A1 (no) |
JP (1) | JPH05509094A (no) |
AU (1) | AU655192B2 (no) |
CA (1) | CA2088251A1 (no) |
FI (1) | FI930429A0 (no) |
IE (1) | IE912754A1 (no) |
IL (1) | IL99030A0 (no) |
NL (1) | NL9001752A (no) |
NO (1) | NO180084C (no) |
NZ (1) | NZ239234A (no) |
WO (1) | WO1992002503A1 (no) |
ZA (1) | ZA916058B (no) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995013812A1 (de) * | 1993-11-17 | 1995-05-26 | Byk Nederland Bv | Verwendung substituierter 1,4-dihydropyridine zur senkung des augeninnendruckes |
EP1108710A4 (en) * | 1998-07-23 | 2001-11-21 | Chen Ing Jun | GUAIACOXYPROPANOLAMINE WITH ALPHA / BETA ADRENERGIC INHIBIT ACTIVITY |
SE0301010D0 (sv) * | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
LT2797416T (lt) | 2011-12-28 | 2017-10-25 | Global Blood Therapeutics, Inc. | Pakeistieji benzaldehido junginiai ir jų panaudojimo būdai, didinant audinių aprūpinimą deguonimi |
WO2013102145A1 (en) | 2011-12-28 | 2013-07-04 | Global Blood Therapeutics, Inc. | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
SG11201507453VA (en) | 2013-03-15 | 2015-10-29 | Global Blood Therapeutics Inc | Compounds and uses thereof for the modulation of hemoglobin |
US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
JP6426694B2 (ja) | 2013-03-15 | 2018-11-21 | グローバル ブラッド セラピューティクス インコーポレイテッド | ヘモグロビンの修飾のための化合物及びその使用 |
WO2014145040A1 (en) * | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
CN105051044A (zh) | 2013-03-15 | 2015-11-11 | 全球血液疗法股份有限公司 | 化合物及其用于调节血红蛋白的用途 |
US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
EA202092627A1 (ru) | 2013-11-18 | 2021-09-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
PL3102208T3 (pl) | 2014-02-07 | 2021-07-19 | Global Blood Therapeutics, Inc. | Krystaliczny polimorf wolnej zasady 2-hydroksy-6-((2-(1-izopropylo-1h-pirazol-5-ilo)pirydyn-3-ylo)metoksy)benzaldehydu |
MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
SG11201804647TA (en) | 2015-12-04 | 2018-06-28 | Global Blood Therapeutics Inc | Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
AR108435A1 (es) | 2016-05-12 | 2018-08-22 | Global Blood Therapeutics Inc | Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído |
TWI778983B (zh) | 2016-10-12 | 2022-10-01 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
ES2966707T3 (es) | 2018-10-01 | 2024-04-23 | Global Blood Therapeutics Inc | Moduladores de la hemoglobina para el tratamiento de la drepanocitosis |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1670827C3 (de) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
GB1455502A (en) * | 1973-02-20 | 1976-11-10 | Yamanouchi Pharma Co Ltd | 1,4-dihydropyridine derivatives |
JPS58185562A (ja) * | 1982-04-22 | 1983-10-29 | Taisho Pharmaceut Co Ltd | 1,4−ジヒドロピリジン誘導体 |
DE3248548A1 (de) * | 1982-12-29 | 1984-07-05 | Heinrich Mack Nachf., 7918 Illertissen | Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
ES8708211A1 (es) * | 1985-06-14 | 1987-10-01 | Sankyo Co | Un procedimiento para la preparacion de nuevos derivados de 4-(fenil sustituido)-1,4-dihidropiridina. |
DE3521761A1 (de) * | 1985-06-19 | 1987-01-02 | Bayer Ag | Neue 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln |
WO1988005043A1 (en) * | 1986-12-24 | 1988-07-14 | Boehringer Biochemia Robin S.P.A. | New aralkyl-1,4-dihydropyridines, a method for their preparation and pharmaceutical compositions containing them |
DE3833893A1 (de) * | 1988-10-05 | 1990-04-12 | Bayer Ag | Verwendung von basischen nitro-phenyl-dihydropyridin-amiden als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung ueber neue zwischenprodukte |
DE3833892A1 (de) * | 1988-10-05 | 1990-04-12 | Bayer Ag | Basische 4-aryl-dhp-amide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
-
1990
- 1990-08-02 NL NL9001752A patent/NL9001752A/nl not_active Application Discontinuation
-
1991
- 1991-07-31 JP JP3512770A patent/JPH05509094A/ja active Pending
- 1991-07-31 EP EP91913914A patent/EP0541634A1/en not_active Withdrawn
- 1991-07-31 CA CA002088251A patent/CA2088251A1/en not_active Abandoned
- 1991-07-31 US US07/965,270 patent/US5378718A/en not_active Expired - Fee Related
- 1991-07-31 WO PCT/EP1991/001442 patent/WO1992002503A1/en not_active Application Discontinuation
- 1991-07-31 AU AU82801/91A patent/AU655192B2/en not_active Ceased
- 1991-08-01 IL IL99030A patent/IL99030A0/xx unknown
- 1991-08-01 ZA ZA916058A patent/ZA916058B/xx unknown
- 1991-08-02 NZ NZ239234A patent/NZ239234A/en unknown
- 1991-08-02 IE IE275491A patent/IE912754A1/en unknown
-
1993
- 1993-01-29 NO NO930306A patent/NO180084C/no unknown
- 1993-02-01 FI FI930429A patent/FI930429A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO180084B (no) | 1996-11-04 |
US5378718A (en) | 1995-01-03 |
IL99030A0 (en) | 1992-07-15 |
WO1992002503A1 (en) | 1992-02-20 |
NZ239234A (en) | 1994-06-27 |
NO930306D0 (no) | 1993-01-29 |
NL9001752A (nl) | 1992-03-02 |
EP0541634A1 (en) | 1993-05-19 |
FI930429A (fi) | 1993-02-01 |
NO930306L (no) | 1993-01-29 |
JPH05509094A (ja) | 1993-12-16 |
CA2088251A1 (en) | 1992-02-03 |
ZA916058B (en) | 1992-06-24 |
IE912754A1 (en) | 1992-02-12 |
AU8280191A (en) | 1992-03-02 |
FI930429A0 (fi) | 1993-02-01 |
AU655192B2 (en) | 1994-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO180084C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater | |
NO179639C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser | |
FI890282A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi | |
NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
NO176759C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater | |
NO179448C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser | |
NO179283C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler | |
NO176796C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater | |
FI104170B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi | |
NO175978C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
NO176275C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater | |
NO175714C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, aromatiske estere | |
NO175429C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive 16-dehydro-vitamin-D3-derivater | |
NO173334C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner | |
NO175976C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater | |
NO177096C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner | |
FI873350A (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi | |
NO168107C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner | |
NO173503C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidayo (1,4) benzodiazepin-2-tioner | |
NO174892C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte dihydropyrrolizinforbindelser | |
NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive | |
NO960307D0 (no) | Fremgangsmåte ved fremstilling av substituerte 4,6-diamino-5-cyanopyrimidiner | |
NO179790C (no) | Fremgangsmåte ved fremstilling av 2,3,5,6-tetraklorpyridin | |
NO179101C (no) | Fremgangsmåte for fremstilling av dibeskyttet 2,3-hydroksymetyl-cyklobutanol | |
FI93216C (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi |